ASH 2021-- White Blood Counts Key to Managing Th... - MPN Voice

MPN Voice

10,775 members14,963 posts

ASH 2021-- White Blood Counts Key to Managing Thrombotic Events in Polycythemia Vera

EPguy profile image
4 Replies

Another post there.

cancernetwork.com/view/whit...

<<there was an association between elevated blood counts and thrombotic events, particularly a white blood cell count over 11 in all patients>> This has been shown before, but this seems to be a deeper study.

<<We should be moving beyond the conventional risk models, and start to include additional factors—whether we're talking about blood counts, allele burdens, even lymphocyte counts, perhaps—to make better models to predict thrombosis>> I agree, esp about allele, but we know it's "complicated".

Written by
EPguy profile image
EPguy
To view profiles and participate in discussions please or .
4 Replies
gvibes profile image
gvibes

ETguy, Thanks for the information (again) - depth of understanding of these things is so important. Curious if they came up with a reason why high white counts caused thrombotic events. Is it related to viscosity of blood or something else? I skimmed the paper but couldnt figure this out. Did you see a reason?

thanks

EPguy profile image
EPguy in reply to gvibes

Like so much with MPN, the Why is weak in my readings on WBC vs PV. Same for INF, its details of action are not that well understood. Good thing is we at least can control WBC etc even if how that control works, or why we need to, is still being studied.

There are few rationally designed drugs for MPN, Rux is one I believe, which followed the discovery of JAK2 mutation. Bomedemstat in trials is another. Many of the recent "whys" are resulting from deeper genetic understandings that are only in the last few years getting ripe.

Meatloaf9 profile image
Meatloaf9

Thanks for posting this and all the information you keep us appraised of. Glad to see that my MPN specialist, Aaron Gerds, is keeping busy on the MPN front. Again, thanks for all the articles you post and the links to those articles.

Bluetop profile image
Bluetop

Thanks for posting this -much appreciated.

Not what you're looking for?

You may also like...

Outcomes of JAK2 V617F-positive polycythemia vera and ET according to the JAK2 V617F allele burden

« JAK2 V617F allele burdens were positively correlated with white blood cell counts, hemoglobin...

Neutrophil-to-Lymphocyte Ratio May Predict Thrombotic Events in Polycythemia Vera

Neutrophil-to-Lymphocyte Ratio May Predict Thrombotic Events in Polycythemia Vera Vicki Moore,......

Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

« Several lines of evidence suggest other factors contribute to the propensity to develop...

JAK2 V617F Allele Burden and Thrombotic Events in Patients w/ JAK2 V617F Positive PCV/ET @ High Risk of Thrombosis

Background: The goal of therapy of polycythemia vera (PV) and essential thrombocythemia (ET)...

JAK2V617F allele burden in polycythemia vera: burden of proof

« The JAK2V617F variant allele frequency (VAF) is a key determinant of outcomes in PV, including...